3-hydroxyflavone has been researched along with Leukemia-Lymphoma, Adult T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, N; Hasegawa, H; Hayashi, M; Ishibashi, M; Kam, TS; Kamihira, S; Komiyama, K; Koyano, T; Masuda, M; Murata, K; Sakai, T; Sugahara, K; Takasu, N; Tsukasaki, K; Tsuruda, K; Yamada, Y; Yoshida, T | 1 |
1 other study(ies) available for 3-hydroxyflavone and Leukemia-Lymphoma, Adult T-Cell
| Article | Year |
|---|---|
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Asteraceae; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Flavonols; Humans; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Plant Extracts; Promoter Regions, Genetic; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Small Interfering; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2006 |